Search research articles
Contact Us
Filters
Showing results (101-110 of 182) with videos related to
Page
of 19
Sort By:
American Journal of Hematology
|
August 24, 2023
Safety of radiotherapy for second primary malignancies in patients with chronic lymphocytic leukemia receiving concurrent novel agent treatment
Samuel R Kosydar, Sameer A Parikh, Scott C Lester, et al.
Leukemia
|
February 16, 2022
Associations of history of vaccination and hospitalization due to infection with risk of monoclonal B-cell lymphocytosis
Nicholas J Boddicker, Sara J Achenbach, Sameer A Parikh, et al.
Leukemia
|
March 16, 2019
KRAS, NRAS, and BRAF mutations are highly enriched in trisomy 12 chronic lymphocytic leukemia and are associated with shorter treatment-free survival
Elena Vendramini, Riccardo Bomben, Federico Pozzo, et al.
Leukemia & Lymphoma
|
April 25, 2019
Rapid disease progression following discontinuation of ibrutinib in patients with chronic lymphocytic leukemia treated in routine clinical practice
Paul J Hampel, Wei Ding, Timothy G Call, et al.
Blood
|
August 15, 2022
Progression and survival of MBL: a screening study of 10 139 individuals
Susan L Slager, Sameer A Parikh, Sara J Achenbach, et al.
Leukemia & Lymphoma
|
May 26, 2020
Incidence and risk of tumor lysis syndrome in patients with relapsed chronic lymphocytic leukemia (CLL) treated with venetoclax in routine clinical practice
Amber B Koehler, Nelson Leung, Timothy G Call, et al.
Haematologica
|
February 9, 2018
Outcomes of a large cohort of individuals with clinically ascertained high-count monoclonal B-cell lymphocytosis
Sameer A Parikh, Kari G Chaffee, Melissa C Larson, et al.
Cancers
|
July 13, 2024
Utility of Targeted Sequencing Compared to FISH for Detection of Chronic Lymphocytic Leukemia Copy Number Alterations
J Erin Wiedmeier-Nutor, Chantal E McCabe, Daniel R O'Brien, et al.
Blood
|
August 24, 2016
Validation of the CLL-IPI and comparison with the MDACC prognostic index in newly diagnosed patients
Massimo Gentile, Tait D Shanafelt, Davide Rossi, et al.
American Journal of Hematology
|
December 3, 2019
Addition of venetoclax at time of progression in ibrutinib-treated patients with chronic lymphocytic leukemia: Combination therapy to prevent ibrutinib flare
Paul J Hampel, Timothy G Call, Wei Ding, et al.
Page
of 19
Search research articles
Search
Showing results (101-110 of 182) with videos related to
Sort By:
Page
of 19
American Journal of Hematology
|
August 24, 2023
Safety of radiotherapy for second primary malignancies in patients with chronic lymphocytic leukemia receiving concurrent novel agent treatment
Samuel R Kosydar, Sameer A Parikh, Scott C Lester, et al.
Leukemia
|
February 16, 2022
Associations of history of vaccination and hospitalization due to infection with risk of monoclonal B-cell lymphocytosis
Nicholas J Boddicker, Sara J Achenbach, Sameer A Parikh, et al.
Leukemia
|
March 16, 2019
KRAS, NRAS, and BRAF mutations are highly enriched in trisomy 12 chronic lymphocytic leukemia and are associated with shorter treatment-free survival
Elena Vendramini, Riccardo Bomben, Federico Pozzo, et al.
Leukemia & Lymphoma
|
April 25, 2019
Rapid disease progression following discontinuation of ibrutinib in patients with chronic lymphocytic leukemia treated in routine clinical practice
Paul J Hampel, Wei Ding, Timothy G Call, et al.
Blood
|
August 15, 2022
Progression and survival of MBL: a screening study of 10 139 individuals
Susan L Slager, Sameer A Parikh, Sara J Achenbach, et al.
Leukemia & Lymphoma
|
May 26, 2020
Incidence and risk of tumor lysis syndrome in patients with relapsed chronic lymphocytic leukemia (CLL) treated with venetoclax in routine clinical practice
Amber B Koehler, Nelson Leung, Timothy G Call, et al.
Haematologica
|
February 9, 2018
Outcomes of a large cohort of individuals with clinically ascertained high-count monoclonal B-cell lymphocytosis
Sameer A Parikh, Kari G Chaffee, Melissa C Larson, et al.
Cancers
|
July 13, 2024
Utility of Targeted Sequencing Compared to FISH for Detection of Chronic Lymphocytic Leukemia Copy Number Alterations
J Erin Wiedmeier-Nutor, Chantal E McCabe, Daniel R O'Brien, et al.
Blood
|
August 24, 2016
Validation of the CLL-IPI and comparison with the MDACC prognostic index in newly diagnosed patients
Massimo Gentile, Tait D Shanafelt, Davide Rossi, et al.
American Journal of Hematology
|
December 3, 2019
Addition of venetoclax at time of progression in ibrutinib-treated patients with chronic lymphocytic leukemia: Combination therapy to prevent ibrutinib flare
Paul J Hampel, Timothy G Call, Wei Ding, et al.
Page
of 19